Huang Lei, Dai Fan, Tang Lian, Bao Xiaofeng, Liu Zhaoguo, Huang Chao, Zhang Ting, Yao Wenjuan
School of pharmacy, Nantong University, Nantong, China.
Department of Medicine, Nanjing general hospital of Nanjing Military Command, Nanjing, China.
Cell Physiol Biochem. 2018;49(2):565-577. doi: 10.1159/000492994. Epub 2018 Aug 30.
BACKGROUND/AIMS: This study used Rho-associated protein kinase (ROCK) isoform-selective suppression or a ROCK inhibitor to analyze the roles of ROCK1 and ROCK2 in regulating endothelial dysfunction triggered by oxidized low-density lipoprotein (oxLDL).
ROCK1 or ROCK2 expression in human umbilical vein endothelial cells (HUVECs) was suppressed by small interfering RNA (siRNA). HUVECs were pretreated with 30 μM Y27632 (pan ROCK inhibitor) for 30 min before exposure to 200 μg/mL oxLDL for an additional 24 h. Cell viability was determined by the MTT assay, and cell apoptosis was evaluated by the TUNEL assay. Protein expression and phosphorylation were assessed by Western blot analysis. The morphology of total and phosphorylated vimentin (p-vimentin) and the co-localization of vimentin with vascular cell adhesion molecule 1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1) were detected by the immunofluorescence assay. The adhesion of promonocytic U937 cells to HUVECs was observed by light microscopy.
ROCK2 suppression or Y27632 treatment, rather than ROCK1 deletion, effectively reduced endothelial cell apoptosis and preserved cell survival. ROCK2 suppression exhibited improved vimentin and p-vimentin cytoskeleton stability and decreased vimentin cleavage by attenuating caspase-3 activity. In addition, increased p-vimentin expression induced by oxLDL was significantly inhibited by ROCK2 deletion or Y27632 treatment. In contrast, ROCK1 suppression showed no obvious effects on the vimentin cytoskeleton, but significantly regulated the expression of adhesion molecules. Endothelial ICAM-1 or VCAM-1 expression induced by oxLDL was obviously inhibited by ROCK1 suppression or Y27632 treatment. Moreover, the expression of ICAM-1 induced by oxLDL could also be reduced by ROCK2 suppression. Furthermore, ROCK2 deficiency or Y27632 treatment inhibited the redistribution of adhesion molecules and their co-localization with vimentin caused by oxLDL. These effects resulted in the significant inhibition of monocyte-endothelial adhesion induced by oxLDL.
The results of this study support the novel concept that ROCK1 is involved in oxLDL-induced cell adhesion by regulating adhesion molecule expression, whereas ROCK2 is required for both endothelial apoptosis and adhesion by regulating both the vimentin cytoskeleton and adhesion molecules. Consequently, ROCK1 and ROCK2 have distinct roles in the regulation of oxLDL-mediated endothelial dysfunction.
背景/目的:本研究使用Rho相关蛋白激酶(ROCK)亚型选择性抑制或ROCK抑制剂来分析ROCK1和ROCK2在调节氧化型低密度脂蛋白(oxLDL)引发的内皮功能障碍中的作用。
通过小干扰RNA(siRNA)抑制人脐静脉内皮细胞(HUVECs)中ROCK1或ROCK2的表达。在暴露于200μg/mL oxLDL额外24小时之前,将HUVECs用30μM Y27632(泛ROCK抑制剂)预处理30分钟。通过MTT法测定细胞活力,通过TUNEL法评估细胞凋亡。通过蛋白质印迹分析评估蛋白质表达和磷酸化。通过免疫荧光测定法检测总波形蛋白和磷酸化波形蛋白(p-波形蛋白)的形态以及波形蛋白与血管细胞粘附分子1(VCAM-1)和细胞间粘附分子1(ICAM-1)的共定位。通过光学显微镜观察原单核细胞U937细胞与HUVECs的粘附。
抑制ROCK2或用Y27632处理,而非缺失ROCK1,可有效减少内皮细胞凋亡并维持细胞存活。抑制ROCK2可改善波形蛋白和p-波形蛋白细胞骨架的稳定性,并通过减弱半胱天冬酶-3活性减少波形蛋白的裂解。此外,ROCK2缺失或Y27632处理可显著抑制oxLDL诱导的p-波形蛋白表达增加。相比之下,抑制ROCK1对波形蛋白细胞骨架无明显影响,但显著调节粘附分子的表达。抑制ROCK1或用Y27632处理可明显抑制oxLDL诱导的内皮ICAM-1或VCAM-1表达。此外,抑制ROCK2也可降低oxLDL诱导的ICAM-1表达。此外,ROCK2缺陷或Y27632处理可抑制oxLDL引起的粘附分子重新分布及其与波形蛋白的共定位。这些作用导致oxLDL诱导的单核细胞-内皮细胞粘附受到显著抑制。
本研究结果支持了一个新的概念,即ROCK1通过调节粘附分子表达参与oxLDL诱导的细胞粘附,而ROCK2通过调节波形蛋白细胞骨架和粘附分子在内皮细胞凋亡和粘附中均发挥作用。因此,ROCK1和ROCK2在调节oxLDL介导的内皮功能障碍中具有不同的作用。